home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

The World Cancer Immunotherapy Conference: Challenges & Opportunities in Clinical Development, Clinical Trial Design & Commercialization

 
  August 19, 2011  
     
 
Arrowhead Publishers and Conferences, San Diego, CA
January 25-26, 2012


The World Cancer Immunotherapy Conference is bringing together leading scientists and C-Level executives from across the globe to present research, case studies and viewpoints on various topics integral to a better understanding of the challenges and opportunities facing developers of therapeutic cancer vaccines. 

 

Speakers and panelists at this conference will discuss the following:

 

- Cancer vaccine clinical trial design

- FDA guidance for cancer vaccine developers and regulatory challenges

- Biomarkers as an aid to clinical development of cancer vaccines

- Optimal disease settings for cancer vaccine intervention

- Cancer vaccines in combination therapies

 
 
Organized by: Arrowhead Publishers and Conferences
Invited Speakers: TBA
 
Deadline for Abstracts: TBA
 
Registration: Visit the conference website
E-mail: john.waslif@arrowheadpublishers.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.